Vigil Neuroscience Inc (VIGL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Ivana Magovcevic-Liebisch
Employees:
40
400 TECHNOLOGY SQUARE, 10TH FLOOR, CAMBRIDGE, MA 02139
857-254-4445

Vigil Neuroscience, Inc. engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) The company also develops a small molecule TREM2 agonist suitable for oral delivery.

Data derived from most recent annual or quarterly report
Market Cap 310.687 Million Shares Outstanding28.27 Million Avg 30-day Volume 27.501 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value1.4718 Operating Margin0.0 Enterprise Value99.197 Million
Current Ratio22.188 EPS Growth0 Quick Ratio21.242
1 Yr BETA 1.0773 52-week High/Low 18.27 / 2.18 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score19.289 Free Cash Flow to Firm 0
View SEC Filings from VIGL instead.

View recent insider trading info

Funds Holding VIGL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VIGL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-02:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-07:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    300 total shares from 1 transactions

    Exercise Derivative Conversion (M)

    300 total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PAPAPETROPOULOS SPYROS CHIEF MEDICAL OFFICER

    • Officer
    153,604 2022-11-18 4

    BRUHN SUZANNE LOUISE

    • Director
    0 2022-07-27 2

    THISTLE MARY

    • Director
    12,155 2022-06-09 3

    BLANCHARD CHERYL R

    • Director
    12,155 2022-06-09 3

    BOOTH BRUCE

    • Director
    5,849,029 2022-06-09 4

    VITOROVIC STEFAN

    • Director
    5,028,084 2022-06-09 3

    KOENIG GERHARD

    • Director
    12,155 2022-06-09 3

    THORP CLAY

    • Director
    1,559,030 2022-05-16 4

    THACKABERRY EVAN SVP, HEAD OF EARLY DEVELOPMENT

    • Officer
    1,500 2022-05-05 2

    ZIOLKOWSKI JENNIFER LYNN CHIEF FINANCIAL OFFICER

    • Officer
    4,000 2022-05-03 3

    VERNI CHRISTOPHER GENERAL COUNSEL

    • Officer
    4,000 2022-05-03 3

    MAGOVCEVIC-LIEBISCH IVANA PRESIDENT AND CEO

    • Officer
    • Director
    203,687 2022-05-02 3

    AMGEN INC

    • 10% Owner
    0 2022-01-11 2

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND IV LP

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    616,786 2022-01-11 2

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    192,973 2022-01-11 2

    ATLAS VENTURE FUND XII, L.P.

    ATLAS VENTURE ASSOCIATES XII, L.P.

    ATLAS VENTURE ASSOCIATES XII, LLC

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • 10% Owner
    5,836,874 2022-01-11 2

    VIDA VENTURES GP III, L.L.C.

    VIDA VENTURES III, L.P.

    VIDA VENTURES III-A, L.P.

    • 10% Owner
    5,015,929 2022-01-11 2

    NORTHPOND VENTURES GP, LLC

    NORTHPOND VENTURES, LP

    NORTHPOND VENTURES GP II, LLC

    NORTHPOND VENTURES II, LP

    RUBIN MICHAEL P.

    • 10% Owner
    4,214,498 2022-01-11 2

    GANDHI SHAAN-CHIRAG C

    • Director
    0 2022-01-06 1

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PAPAPETROPOULOS SPYROS - Officer CHIEF MEDICAL OFFICER

    2022-11-22 21:45:28 -0500 2022-11-18 M 300 $1.89 a 4,300 direct 1.4774 1.4774 2 0.0 1

    PAPAPETROPOULOS SPYROS - Officer CHIEF MEDICAL OFFICER

    2022-11-22 21:45:28 -0500 2022-11-18 S 300 $14.00 d 4,000 direct yes 1.4774 1.4774 2 0.0 1

    PAPAPETROPOULOS SPYROS - Officer CHIEF MEDICAL OFFICER

    2022-11-22 21:45:28 -0500 2022-11-18 M 300 d 149,604 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 22:15:03 UTC -15.9544 19.7744 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 21:45:04 UTC -15.9544 19.7744 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 21:15:03 UTC -15.9544 19.7744 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 20:45:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 20:15:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 19:45:04 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 19:15:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 18:45:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 18:15:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 17:45:04 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 17:15:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 16:45:04 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 16:15:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 15:45:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 15:15:03 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 14:45:04 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 14:15:04 UTC -16.67 20.49 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 13:45:03 UTC -18.2456 22.0656 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 13:15:03 UTC -18.2456 22.0656 500000
    VIGIL NEUROSCIENCE INC VIGL 2022-11-25 12:45:03 UTC -18.2456 22.0656 500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments